Find out how we’re advancing allergen consciousness in foodservice by our Knowledgeable Eating pilot with Public Well being Inspectors. Discover out how one can take part in a analysis alternative for youngsters with tree nut allergy. Examine new analysis on peanut oral immunotherapy, and get an replace on latest examine findings in regards to the VIASKIN® Peanut patch.
Advocacy in motion: Advancing allergen consciousness in foodservice
To kick off 2026, we expanded our Knowledgeable Eating pilot venture with Middlesex-London Public Well being in Ontario and Université Laval to boost meals allergy training inside foodservice. This initiative permits Public Well being Inspectors to lift consciousness about meals allergy throughout routine restaurant inspections by sharing our Suppose Meals Allergy assets. That is now the second Ontario Public Well being unit to take part on this pilot, following a implausible yr with Wellington-Dufferin-Public Well being Unit championing this effort.
By coaching by Meals Allergy Canada on allergen administration and communication, inspectors at the moment are extra geared up to information meals companies in creating safer eating experiences. All through 2026, we plan to proceed to have interaction extra well being models nationwide to implement comparable initiatives.
We thank Wellington-Dufferin-Guelph Public Well being and Middlesex-London Public Well being for main this effort, making a significant influence on allergen consciousness in native eating places. We’re excited for the longer term growth of this initiative!
Analysis examine: Name for participation for youngsters with tree nut allergy
A analysis examine is underway in Hamilton, Ontario. The researchers are in search of kids aged 1-16 years who’ve been identified with tree nut allergy, particularly to cashew, pistachio, walnut, pecan, almond, or hazelnut.
The examine is testing completely different immunotherapies to desensitize an individual with tree nut allergy by repeated exposures to very small quantities of tree nut by sublingual immunotherapy (SLIT) or low-dose oral immunotherapy (IdOIT). SLIT is when a meals allergen is positioned below the tongue and OIT is when a meals allergen is eaten.
Meals Allergy Canada is concerned on this analysis by a affected person/caregiver partnership the place we offer enter on the design of the analysis, overview analysis outcomes, and make sure the affected person perspective is taken into account.
Learn extra particulars in regards to the examine from the analysis workforce. To be taught extra in regards to the examine and in case your baby is eligible to take part, full this type or e mail [email protected].
Please share with others whose kids have tree nut allergy.
Analysis: Low dose peanut oral immunotherapy (OIT) might assist defend children with peanut allergy
A brand new examine finds a considerably decrease dose of peanut OIT might present children with comparable safety from unintentional publicity compared to normal remedy.
Peanut OIT will increase the quantity of peanut that may be eaten earlier than experiencing an allergic response. With this remedy, kids with peanut allergy eat a progressively rising quantity of peanut over time till they attain a “upkeep” dose that’s eaten recurrently, even after the remedy, to assist sustain their safety towards unintentional publicity.
Within the examine, kids with peanut allergy had been assigned to considered one of three teams: low dose remedy (30 mg upkeep), standard-dose remedy (300 mg upkeep) or avoidance (no peanut OIT). Each peanut OIT remedy teams skilled important will increase of their threshold to peanuts, which means they had been in a position to tolerate a bigger amount of the allergen.
This examine is the primary of its variety to judge whether or not a a lot smaller dose of peanut OIT works in comparison with the usual dose. The findings present {that a} dose 10 instances decrease should be efficient—making remedy extra accessible and serving to to guard extra kids with peanut allergy.
Two members of our Healthcare Advisory Board had been concerned with this examine: Dr. Julia Upton, co-first writer and Dr. Moshe Ben-Shoshan, co-senior writer. Learn the press releases: The Hospital for Sick Kids (SickKids) and Montreal Kids’s Hospital.
We are going to maintain you up to date with meals allergy remedy information, and proceed working to make sure Canadians have accessibility to remedy choices.
Analysis: Peanut patch examine exhibits encouraging outcomes
DBV Applied sciences has shared encouraging outcomes from VITESSE, a medical trial evaluating the VIASKIN® Peanut Patch for youngsters with peanut allergy.
The examine centered on kids aged 4-7 and examined whether or not sporting the patch each day might assist make them much less delicate to small, unintentional quantities of peanut. After one yr, practically half of the kids (46.6%) who used the patch had been higher in a position to tolerate peanut than earlier than remedy. The most typical unintended effects had been gentle pores and skin reactions, resembling redness or itching, the place the patch was utilized.
Primarily based on these outcomes, DBV is constant the method wanted to maneuver this remedy ahead for regulatory overview and plans to submit a Biologics License Software (BLA) to the U.S. FDA within the first half of this yr.
We are going to proceed to comply with the newest in meals allergy therapies and maintain you up to date on developments, together with advocating in your behalf to have choices for Canadians.
Mythbuster: Highlights from 2025
Learn beneath for the highest mythbusters shared in earlier years, subjects embody milk allergy, testing and analysis, and allergic reactions.
Assist us educate your communities and share this mythbuster with them! Discover extra mythbusters at foodallergycanada.ca/mythbusters.
Tags: foodservice, mythbuster, TRADE examine, VITESSE Examine
